ACTRN12607000485437已完成不适用
S-Adenosylmethionine (SAM-e) for the treatment of symptoms of fibromyalgia: A double-blind, randomised, placebo controlled trial.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 -2147483648 No limit（—）
- 性别
- All
入选标准
- •Diagnosis of Fibromyalgia by a medical practitioner.
排除标准
- •Pregnancy, Concurrent manic illness.
研究者
相似试验
招募中
不适用
The use of a natural medicine, S-adenolsylmethionine (SAM-e) in the treatment of Fibromyalgia and Chronic Fatigue SyndromeMusculoskeletal - Other muscular and skeletal disordersChronic Fatigue SyndromeFibromyalgiaACTRN12607000377437Deakin University120
尚未招募
不适用
(S)-S-adenosylmethionine (SAMe) in the treatment of pre-menstrual spectrum disorders in adult women: An open-label pilot studyPremenstrual Dysphoric DisorderMental Health - Other mental health disordersReproductive Health and Childbirth - Menstruation and menopausePremenstrual SyndromeACTRN12621001269820Alfred Health30
已完成
3 期
utraceuticals as Adjunctive Treatments in Major Depressive Disorder (NAT-D): A Double-Blind, Randomised, Placebo-Controlled TrialMental Health - DepressionDepressionACTRN12613001300763niversity of Melbourne300
已完成
2 期
utraceuticals as Monotherapy Treatments in Major Depressive Disorder: A Double-Blind, Randomised, Placebo-Controlled TrialDepressionACTRN12613001299796niversity of Melbourne60
进行中（未招募）
不适用
Efficacy and safety of S-adenosil-methionine on depression of patients with Lesch - Nyhan Syndrome - NDEUCTR2007-004036-23-ITFONDAZIONE MALATTIE RARE MAURO BASCHIROTTO B.I.R.D. ONLUS